MDalert.com is designed to help physicians in all specialties succeed in this new world of performance-driven healthcare.
July 2, 2020

FDA Approves Atezolizumab/Bevacizumab Combo for Unresectable, Metastatic HCC

By Michael Vlessides, /alert Contributor
Patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy have a new treatment option in atezolizumab plus bevacizumab...
FDA Approves Atezolizumab/Bevacizumab Combo for Unresectable, Metastatic HCC
July 1, 2020

FDA Approves New Administration Option for Dupilumab

By Adam Hochron

The FDA has approved a new 300mg pre-filled pen for dupilumab to treat several conditions, including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. The approval is for patients age 12 and above...

FDA Approves New Administration Option for Dupilumab
June 30, 2020

Etanercept Effective for Steroid-Refractory GVHD, but High Infection Rates Persist

By Cameron Kelsall, /alert Contributor
Etanercept, often administered in conjunction with extracorporeal photopheresis, improved steroid-refractory graft-versus-host disease...
Etanercept Effective for Steroid-Refractory GVHD, but High Infection Rates Persist
June 29, 2020

Selinexor Approved for Relapsed or Refractory Diffuse Large B-cell Lymphoma

By MD /alert Staff
The FDA has approved selinexor for relapsed or refractory diffuse large B-cell lymphoma...
Selinexor Approved for Relapsed or Refractory Diffuse Large B-cell Lymphoma
June 27, 2020

FDA Approves Injection Treatment for Diabetes

By Adam Hochron
The FDA has approved a new insulin glargine injection to control high blood sugar in adults with type 2 diabetes and adults and children with type 1 diabetes...
FDA Approves Injection Treatment for Diabetes
View More
Loading...

Trending News

In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Reuters Health Medical News

Critically ill children more likely to die when underweight, but not when obese

By Linda Carroll (Reuters Health) - Being underweight may raise mortality risk among children who are critically ill, but being overweight appears to have no impact, a new study suggests. In an Read More »

Regeneron, Sanofi arthritis drug fails late-stage study in COVID-19 patients

By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a late-stage study testing it in COVID- Read More »

COVID-19 associated loss of smell, taste mostly resolves within weeks

By Linda Carroll (Reuters Health) - Most adults with a mild form of COVID-19 who have lost their ability to taste or smell as an early disease symptom will get those senses back, at least in part, a Read More »

Pharmacists expanded their antimicrobial stewardship role during pandemic

By Marilynn Larkin NEW YORK (Reuters Health) - To help limit hospital staff contact with SARS-CoV-2 patients, pharmacists at a university hospital consolidated the number of times medications needed Read More »

Aimmune says patients begin treatment with peanut allergy drug as COVID-19 lockdowns ease

By Carl O'Donnell and Manas Mishra (Reuters) - Aimmune Therapuetics Inc said its peanut allergy drug, whose launch had been paused because of coronavirus lockdowns, is again being administered to Read More »

Health workers with appropriate PPE don't get COVID-19

By Lisa Rappaport (Reuters Health) - Health workers who have appropriate personal protective equipment (PPE) including protective suits, masks, gloves, goggles, face shields, and gowns don't develop Read More »

Sierra Leone doctors' strike leaves COVID-19 patients stranded

By Cooper Inveen Freetown (Reuters) - Doctors treating COVID-19 patients in Sierra Leone went on strike on Thursday over unpaid bonuses, leaving patients in some of the main treatment centres without Read More »

Moderna's COVID-19 vaccine trial delayed - STAT

By Reuters Staff (Reuters) - Shares of Moderna Inc fell 7% on Thursday after medical news site STAT reported a delay in a large trial testing the biotech's potential coronavirus vaccine as the company Read More »

See all news »

Clinical Trials

Use our ClinicalTrials.gov feed to find trials in which your patients could enroll. In some cases, experimental drugs are a patient’s only hope. This section will regularly report on trials in the most common disease states, as they are getting underway.


© 2020 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information